GenesisCare, an oncology provider in the United States, Australia, Spain, and the United Kingdom, announced on Monday that it has named Bridget F Koontz, MD as its new US chief medical officer- Deputy Group CMO, and Neal D Shore, MD, FACS as its new US chief medical officer of Surgery and Urology.

Presently, Dr Koontz serves as associate professor at Duke University and as director of Radiation Oncology for Duke Cancer Institute's Center for Prostate and Urologic Cancers. She has more than 13 years of leadership experience.

Dr Shore intends to utilise his more than 30 years of urologic oncology expertise to improve patients' outcomes at GenesisCare's 290 advanced cancer care facilities across 21 states. He has served on various executive, urology, government, and administrative boards throughout his career, including the Society of Urologic Oncology and the Bladder Cancer Advocacy Network.